241 results
Page 3 of 13
8-K
EX-99.1
4ep3ssofkk84r s9s
9 Nov 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
j6b23g98
20 Oct 21
Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
9:13am
8-K
EX-99.1
8r08anm
14 Sep 21
Regulation FD Disclosure
5:00pm
8-K
jixjvqnlxtvn8j1t09l
14 Sep 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
x9m5d8jdnws6z
10 Sep 21
Other Events
6:01am
424B5
fcr6c1a3
13 Aug 21
Prospectus supplement for primary offering
5:08pm
8-K
EX-99.1
b4saxh3wwxrj1ovuj
12 Aug 21
Humanigen Reports Second Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
islnc 2d4vwq2pwt1e
4 Aug 21
Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
6:04am
8-K
EX-99.2
9j9fmg3r4n 2t1
4 Aug 21
Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
6:04am
8-K
o2p9n7r
4 Aug 21
Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients
6:04am
8-K
z4xn rkbnj
14 Jul 21
Regulation FD Disclosure
11:58am
8-K
EX-99.1
yjsi6pc
14 Jul 21
Regulation FD Disclosure
11:58am
8-K
rgd4f pcnm
17 Jun 21
Humanigen 2021 Annual Stockholder Meeting June 17
6:30am
8-K
EX-99.1
1xd5bzx2zre eeq12
17 Jun 21
Humanigen 2021 Annual Stockholder Meeting June 17
6:30am
8-K
EX-99.1
l9ngnd89
28 May 21
Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19
5:00pm